Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel monoclonal antibodies patented by IRM and Novartis

Sep. 6, 2012

BioSante Pharmaceuticals reports phase III safety data for LibiGel

Sep. 5, 2012

Stem cell gene therapy improves erectile dysfunction in rats

Sep. 5, 2012

New series of GPR119 agonists optimized by Bristol-Myers Squibb

Sep. 4, 2012

Silodosin evaluated for premature ejaculation

Sep. 4, 2012

Novo Nordisk gives update on approval of insulin degludec in Japan

Sep. 3, 2012

Bristol-Myers Squibb profiles novel MCH1 receptor antagonist

Sep. 3, 2012

Mechanism of action of epelsiban besilate further elucidated

Sep. 3, 2012

CB2 receptor agonist proves useful for the treatment of erectile dysfunction

Sep. 3, 2012

Takeda presents novel inhibitors of ACC2

Sep. 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...